Kate S Carroll Selected Research

Kate S Carroll Research Topics

Disease

7	Infections 01/2022 - 11/2008
6	Neoplasms (Cancer) 11/2018 - 09/2009
5	Tuberculosis (Tuberculoses) 06/2021 - 09/2009
2	Thrombosis (Thrombus) 01/2023 - 01/2020
2	Latent Tuberculosis 01/2015 - 11/2008
2	Latent Infection 01/2011 - 09/2009
1	COVID-19 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Scrapie 01/2022
1	Vascular Remodeling 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2020
1	Fibrosis (Cirrhosis) 12/2018
1	Cysts 12/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2018
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Melanoma (Melanoma, Malignant) 09/2013
1	Atrial Fibrillation 09/2012
1	Pulmonary Hypertension 09/2012
1	Breast Neoplasms (Breast Cancer) 09/2009
1	Carcinogenesis 09/2009

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2009
6	Oxidoreductases (Dehydrogenase)IBA 01/2023 - 01/2011
4	Cysteine (L-Cysteine)FDA Link 01/2020 - 09/2009
4	Adenosine Phosphosulfate (Adenylyl Sulfate)IBA 01/2015 - 01/2011
3	Sulfhydryl Compounds (Thiols)IBA 01/2022 - 09/2009
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2017
3	Sulfenic AcidsIBA 01/2017 - 09/2009
3	Sulfates (Sulfates, Inorganic)IBA 09/2013 - 11/2008
3	adenylylsulfate reductaseIBA 09/2013 - 11/2008
2	oxidized low density lipoproteinIBA 01/2023 - 01/2020
2	(2R,3R,4R,5S)- 6- (((2S,3R,4R,5R)- 2,3,4,5,6- pentahydroxyhexyl)- (2- (4- (sulfanylmethyl)phenoxy)ethyl)amino)hexane- 1,2,3,4,5- pentolIBA 01/2022 - 12/2018
2	EnzymesIBA 01/2015 - 09/2009
2	SulfurIBA 01/2015 - 09/2013
2	Melanocyte-Stimulating Hormones (MSH)IBA 01/2014 - 08/2011
2	mycothiolIBA 01/2014 - 08/2011
2	Antitubercular AgentsIBA 01/2011 - 09/2009
2	Iron-Sulfur ProteinsIBA 01/2011 - 09/2009
1	Protein Disulfide-IsomerasesIBA 01/2023
1	Oxidants (Oxidizing Agents)IBA 01/2023
1	P-2165IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	AmmoniaIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	IminesIBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Reducing AgentsIBA 01/2022
1	Angiotensin IIIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2020
1	src-Family KinasesIBA 01/2020
1	LipidsIBA 01/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2020
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2018
1	Expectorants (Mucolytics)IBA 12/2018
1	Protein CIBA 12/2018
1	MucinsIBA 12/2018
1	Surface-Active Agents (Surfactants)IBA 12/2018
1	indium-bleomycinIBA 12/2018
1	PeroxiredoxinsIBA 11/2018
1	cysteine sulfinic acidIBA 11/2018
1	ProteomeIBA 01/2017
1	IronIBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	PolymersIBA 09/2013
1	Horseradish PeroxidaseIBA 09/2012
1	StreptavidinIBA 09/2012
1	AntibodiesIBA 09/2009
1	Indicators and Reagents (Reagents)IBA 09/2009

Therapy/Procedure

1	Aftercare (After-Treatment) 09/2013
1	Therapeutics 09/2009
1	Drug Therapy (Chemotherapy) 11/2008